|
1
|
Kamihara J, Bourdeaut F, Foulkes WD,
Molenaar JJ, Mossé YP, Nakagawara A, Parareda A, Scollon SR,
Schneider KW, Skalet AH, et al: Retinoblastoma and neuroblastoma
predisposition and surveillance. Clin Cancer Res. 23:e98–e106.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramirez-Ortiz MA, Lansingh VC, Eckert KA,
Haik BG, Phillips BX, Bosch-Canto V, González-Pérez G,
Villavicencio-Torres A and Etulain-González A: Systematic review of
the current status of programs and general knowledge of diagnosis
and management of retinoblastoma. Bol Med Hosp Infant Mex.
74:41–54. 2017.
|
|
3
|
Bansal A, Noronha V, Krishnakumar S and
Khetan V: A tale of absent crystalline lens in an eye with
retinoblastoma. Ocul Oncol Pathol. 4:250–253. 2018. View Article : Google Scholar
|
|
4
|
Errico A: Cancer therapy:
Retinoblastoma-chemotherapy increases the risk of secondary cancer.
Nat Rev Clin Oncol. 11:6232014. View Article : Google Scholar
|
|
5
|
Rojanaporn D, Boontawon T,
Chareonsirisuthigul T, Thanapanpanich O, Attaseth T, Saengwimol D,
Anurathapan U, Sujirakul T, Kaewkhaw R and Hongeng S: Spectrum of
germline RB1 mutations and clinical manifestations in
retinoblastoma patients from Thailand. Mol Vis. 24:778–788.
2018.
|
|
6
|
Soliman SE, Racher H, Zhang C, MacDonald H
and Gallie BL: Genetics and molecular diagnostics in
retinoblastoma-an update. Asia Pac J Ophthalmol (Phila). 6:197–207.
2017.
|
|
7
|
Wang Y, Yuan J, Yang L, Wang P, Wang X, Wu
Y, Chen K, Ma R, Zhong Y, Guo X, et al: Inhibition of migration and
invasion by berberine via inactivation of PI3K/Akt and p38 in human
retino-blastoma cell line. Adv Clin Exp Med. 27:899–905. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abramson DH, Shields CL, Munier FL and
Chantada GL: Treatment of retinoblastoma in 2015: Agreement and
disagreement. JAMA Ophthalmol. 133:1341–1347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The land-scape of long noncoding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing Y, Zhao Z, Zhu Y, Zhao L, Zhu A and
Piao D: Comprehensive analysis of differential expression profiles
of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic
signature for patients with colon adenocarcinoma. Oncol Rep.
39:2365–2375. 2018.PubMed/NCBI
|
|
11
|
Wu Y, Shao A, Wang L, Hu K, Yu C, Pan C
and Zhang S: The role of lncRNAs in the distant metastasis of
breast cancer. Front Oncol. 9:4072019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xuan W, Yu H, Zhang X and Song D:
Crosstalk between the lncRNA UCA1 and microRNAs in cancer. FEBS
Lett. 593:1901–1914. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu W, Liu H, Wang X, Lu J and Yang W:
Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
Pathol Res Pract. 215:1524292019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu C, Hu C, Wang Y and Liu S: Long
noncoding RNA SNHG16 promotes human retinoblastoma progression via
sponging miR-140-5p. Biomed Pharmacother. 117:1091532019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han N, Zuo L, Chen H, Zhang C, He P and
Yan H: Long non-coding RNA homeobox A11 antisense RNA (HOXA11-AS)
promotes retinoblastoma progression via sponging miR-506-3p. Onco
Targets Ther. 12:3509–3517. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Quan LJ and Wang WJ: FEZF1-AS1 functions
as an oncogenic lncRNA in retinoblastoma. Biosci Rep.
39:BSR201907542019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu XZ, Cui HP, Lv HJ and Feng L: Knockdown
of lncRNA PVT1 inhibits retinoblastoma progression by sponging
miR-488-3p. Biomed Pharmacother. 112:1086272019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bi LL, Han F, Zhang XM and Li YY: LncRNA
MT1JP acts as a tumor inhibitor via reciprocally regulating
Wnt/β-Catenin pathway in retinoblastoma. Eur Rev Med Pharmacol Sci.
22:4204–4214. 2018.PubMed/NCBI
|
|
19
|
Zhang A, Shang W, Nie Q, Li T and Li S:
Long non-coding RNA H19 suppresses retinoblastoma progression via
counteracting miR-17-92 cluster. J Cell Biochem. 119:3497–3509.
2018. View Article : Google Scholar
|
|
20
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chandra S, Vimal D, Sharma D, Rai V, Gupta
SC and Chowdhuri DK: Role of miRNAs in development and disease:
Lessons learnt from small organisms. Life Sci. 185:8–14. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Voorhoeve PM: MicroRNAs: Oncogenes, tumor
suppressors or master regulators of cancer heterogeneity? Biochim
Biophys Acta. 1805:72–86. 2010.
|
|
24
|
Li W, Wang J, Zhang D, Zhang X, Xu J and
Zhao L: MicroRNA-98 targets HMGA2 to inhibit the development of
retinoblastoma through mediating Wnt/β-catenin pathway. Cancer
Biomark. 25:79–88. 2019. View Article : Google Scholar
|
|
25
|
Delsin LEA, Salomao KB, Pezuk JA and
Brassesco MS: Expression profiles and prognostic value of miRNAs in
retinoblastoma. J Cancer Res Clin Oncol. 145:1–10. 2019. View Article : Google Scholar
|
|
26
|
Liao Y, Yin X, Deng Y and Peng X:
MiR-140-5p suppresses retinoblastoma cell growth via inhibiting
c-Met/AKT/mTOR pathway. Biosci Rep. 38:BSR201807762018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Q, Teng Y, Wang R, Deng D, You Y,
Peng Y, Shao N and Zhi F: The long non-coding RNA SNHG14 inhibits
cell proliferation and invasion and promotes apoptosis by sponging
miR-92a-3p in glioma. Oncotarget. 9:12112–12124. 2018.PubMed/NCBI
|
|
28
|
Zhang Z, Wang Y, Zhang W, Li J, Liu W and
Lu W: Long non-coding RNA SNHG14 exerts oncogenic functions in
non-small cell lung cancer through acting as an miR-340 sponge.
Biosci Rep. 39:BSR201809412019. View Article : Google Scholar :
|
|
29
|
Ji N, Wang Y, Bao G, Yan J and Ji S:
LncRNA SNHG14 promotes the progression of cervical cancer by
regulating miR-206/YWHAZ. Pathol Res Pract. 215:668–675. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang YY, Li M, Xu YD and Shang J: LncRNA
SNHG14 promotes the development of cervical cancer and predicts
poor prognosis. Eur Rev Med Pharmacol Sci. 23:3664–3671.
2019.PubMed/NCBI
|
|
31
|
Li L, Zhang R and Li SJ: Long noncoding
RNA SNHG14 promotes ovarian cancer cell proliferation and
metastasis via sponging miR-219a-5p. Eur Rev Med Pharmacol Sci.
23:4136–4142. 2019.PubMed/NCBI
|
|
32
|
Zhao YL and Huang YM: LncSNHG14 promotes
ovarian cancer by targeting microRNA-125a-5p. Eur Rev Med Pharmacol
Sci. 23:3235–3242. 2019.PubMed/NCBI
|
|
33
|
Xie SD, Qin C, Jin LD, Wang QC, Shen J,
Zhou JC, Chen YX, Huang AH, Zhao WH and Wang LB: Long noncoding RNA
SNHG14 promotes breast cancer cell proliferation and invasion via
sponging miR-193a-3p. Eur Rev Med Pharmacol Sci. 23:2461–2468.
2019.PubMed/NCBI
|
|
34
|
Li J, Wang AS, Wang S, Wang CY, Xue S,
Guan H, Li WY, Ma TT and Shan YX: LncSNHG14 promotes the
development and progression of bladder cancer by targeting
miRNA-150-5p. Eur Rev Med Pharmacol Sci. 23:1022–1029.
2019.PubMed/NCBI
|
|
35
|
Liu Z, Yan Y, Cao S and Chen Y: Long
non-coding RNA SNHG14 contributes to gastric cancer development
through targeting miR-145/SOX9 axis. J Cell Biochem. 119:6905–6913.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu S, Hu C, Wang Y, Shi G, Li Y and Wu H:
MiR-124 inhibits proliferation and invasion of human retinoblastoma
cells by targeting STAT3. Oncol Rep. 36:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ortiz MV and Dunkel IJ: Retinoblastoma. J
Child Neurol. 31:227–236. 2016. View Article : Google Scholar
|
|
38
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
39
|
Han X, Huang T and Han J: Long noncoding
RNA VPS9D1-AS1 augments the malignant phenotype of non-small cell
lung cancer by sponging microRNA-532-3p and thereby enhancing HMGA2
expression. Aging (Albany NY). 12:370–386. 2020. View Article : Google Scholar
|
|
40
|
Jia J, Wang J, Yin M and Liu Y:
MicroRNA-605 directly targets SOX9 to alleviate the aggressive
phenotypes of glioblastoma multiforme cell lines by deactivating
the PI3K/Akt pathway. Onco Targets Ther. 12:5437–5448. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Klec C, Prinz F and Pichler M: Involvement
of the long noncoding RNA NEAT1 in carcinogenesis. Mol Oncol.
13:46–60. 2019. View Article : Google Scholar :
|
|
42
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:E13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shuwen H, Qing Z, Yan Z and Xi Y:
Competitive endogenous RNA in colorectal cancer: A systematic
review. Gene. 645:157–162. 2018. View Article : Google Scholar
|
|
44
|
Su S, Gao J, Wang T, Wang J, Li H and Wang
Z: Long non-coding RNA BANCR regulates growth and metastasis and is
associated with poor prognosis in retinoblastoma. Tumour Biol.
36:7205–7211. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gao Y and Lu X: Decreased expression of
MEG3 contributes to retinoblastoma progression and affects
retinoblastoma cell growth by regulating the activity of
Wnt/beta-catenin pathway. Tumour Biol. 37:1461–1469. 2016.
View Article : Google Scholar
|
|
46
|
Dong C, Liu S, Lv Y, Zhang C, Gao H, Tan L
and Wang H: Long non-coding RNA HOTAIR regulates proliferation and
invasion via activating Notch signalling pathway in retinoblastoma.
J Biosci. 41:677–687. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lyu X, Ma Y, Wu F and Wang L and Wang L:
LncRNA NKILA inhibits retinoblastoma by downregulating lncRNA XIST.
Curr Eye Res. 44:975–979. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yan G, Su Y, Ma Z, Yu L and Chen N: Long
noncoding RNA LINC00202 promotes tumor progression by sponging
miR-3619-5p in retinoblastoma. Cell Struct Funct. 44:51–60. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wu K, Li J, Qi Y, Zhang C, Zhu D, Liu D
and Zhao S: SNHG14 confers gefitinib resistance in non-small cell
lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomed
Pharmacother. 116:1089952019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiao P, Hou J, Yao M, Wu J and Ren G:
SNHG14 silencing suppresses the progression and promotes cisplatin
sensitivity in non-small cell lung cancer. Biomed Pharmacother.
117:1091642019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang L, Yang D, Tian R and Zhang H: NEAT1
promotes retinoblastoma progression via modulating miR-124. J Cell
Biochem. 120:15585–15593. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hu C, Liu S, Han M, Wang Y and Xu C:
Knockdown of lncRNA XIST inhibits retinoblastoma progression by
modulating the miR-124/STAT3 axis. Biomed Pharmacother.
107:547–554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Huang J, Yang Y, Fang F and Liu K: MALAT1
modulates the autophagy of retinoblastoma cell through
miR-124-mediated stx17 regulation. J Cell Biochem. 119:3853–3863.
2018. View Article : Google Scholar
|
|
54
|
Liu S, Yan G, Zhang J and Yu L: Knockdown
of long noncoding RNA (lncRNA) metastasis-associated lung
adenocarcinoma transcript 1 (MALAT1) inhibits proliferation,
migration, and invasion and promotes apoptosis by targeting miR-124
in retino-blastoma. Oncol Res. 26:581–591. 2018. View Article : Google Scholar
|
|
55
|
Wagner KU and Schmidt JW: The two faces of
Janus kinases and their respective STATs in mammary gland
development and cancer. J Carcinog. 10:322011. View Article : Google Scholar
|
|
56
|
Xu B, Chen X, Tan J and Xu X: Effect of
AG490 on JAK2/STAT3 signaling pathway in human retinoblastoma
HXO-RB44 cell lines. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
43:1061–1067. 2018.In Chinese. PubMed/NCBI
|
|
57
|
Li Y, Sun W, Han N, Zou Y and Yin D:
Curcumin inhibits proliferation, migration, invasion and promotes
apoptosis of retinoblastoma cell lines through modulation of
miR-99a and JAK/STAT pathway. BMC Cancer. 18:12302018. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu S, Zhang X, Hu C, Wang Y and Xu C:
MiR-29a inhibits human retinoblastoma progression by targeting
STAT3. Oncol Rep. 39:739–746. 2018.
|
|
59
|
Jo DH and Kim JH, Cho CS, Cho YL, Jun HO,
Yu YS, Min JK and Kim JH: STAT3 inhibition suppresses proliferation
of retino-blastoma through down-regulation of positive feedback
loop of STAT3/miR-17-92 clusters. Oncotarget. 5:11513–11525. 2014.
View Article : Google Scholar : PubMed/NCBI
|
